Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Ltd

₹ 121 -6.92%
28 Mar - close price
About

Incorporated in 2015, Co. is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis[1]

Key Points

Business Verticals
A) Manufacturing of Non-Beta-Lactam Medicines and Formulations [1]
It manufactures Non-Beta-Lactam (general) tablets, Non-Beta-Lactam (general) capsules, oral liquid, dry syrup, and external preparations such as Ointment, Lotion, and cream and caters to 162 corporate clients on a loan license and/or contract manufacturing basis

  • Market Cap 134 Cr.
  • Current Price 121
  • High / Low 155 / 97.0
  • Stock P/E 36.0
  • Book Value 38.7
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 3.13 times its book value
  • Debtor days have increased from 57.2 to 70.4 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
19.87 39.75 19.65 18.08 24.97 26.67 25.74
17.96 36.35 17.88 15.67 22.63 24.58 22.82
Operating Profit 1.91 3.40 1.77 2.41 2.34 2.09 2.92
OPM % 9.61% 8.55% 9.01% 13.33% 9.37% 7.84% 11.34%
0.07 0.78 0.01 0.14 0.23 0.05 0.38
Interest 0.29 1.06 0.27 0.64 0.46 0.67 0.99
Depreciation 0.50 1.11 0.56 0.61 0.60 0.78 0.83
Profit before tax 1.19 2.01 0.95 1.30 1.51 0.69 1.48
Tax % 54.62% 49.25% 38.95% 20.77% 34.44% 68.12% 39.86%
0.54 1.02 0.57 1.04 0.98 0.65 0.90
EPS in Rs 2.35 4.43 0.71 1.29 0.89 0.59 0.81
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023 TTM
28.60 48.84 77.48 95.46
26.73 47.38 70.17 85.70
Operating Profit 1.87 1.46 7.31 9.76
OPM % 6.54% 2.99% 9.43% 10.22%
0.22 0.11 0.93 0.80
Interest 0.33 1.03 2.04 2.76
Depreciation 1.40 2.59 2.28 2.82
Profit before tax 0.36 -2.05 3.92 4.98
Tax % 75.00% -15.12% 41.84%
0.09 -2.37 2.29 3.57
EPS in Rs 0.39 -10.30 2.84 3.58
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 39%
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 190%
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023 Sep 2023
Equity Capital 2.30 2.30 8.05 11.05
Reserves 0.76 0.19 11.41 31.68
13.44 17.13 22.04 21.02
13.89 15.08 32.14 35.41
Total Liabilities 30.39 34.70 73.64 99.16
15.99 16.56 25.92 34.80
CWIP 0.00 0.00 0.04 1.60
Investments 0.16 0.30 0.00 0.00
14.24 17.84 47.68 62.76
Total Assets 30.39 34.70 73.64 99.16

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023
0.06 -0.31 8.14
-11.75 -3.23 -11.67
11.40 3.38 13.14
Net Cash Flow -0.29 -0.16 9.61

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2023
Debtor Days 88.83 43.94 70.38
Inventory Days 39.53 44.76 86.93
Days Payable 194.09 120.65 161.82
Cash Conversion Cycle -65.73 -31.95 -4.51
Working Capital Days 14.29 14.95 27.89
ROCE % -5.39%

Shareholding Pattern

Numbers in percentages

4 Recently
Apr 2023Sep 2023
72.85% 72.85%
12.88% 8.51%
14.27% 18.64%
No. of Shareholders 784255

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents